Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$342K Sell
17,928
-1,118
-6% -$24.5K 0.04% 323
2024
Q4
$454K Sell
19,046
-1,942
-9% -$54.2K 0.05% 296
2024
Q3
$588K Sell
20,988
-1,053
-5% -$29.7K 0.06% 289
2024
Q2
$576K Sell
22,041
-229
-1% -$4.76K 0.07% 265
2024
Q1
$487K Buy
22,270
+7,698
+53% +$165K 0.06% 281
2023
Q4
$339K Sell
14,572
-1,367
-9% -$27.5K 0.04% 319
2023
Q3
$314K Sell
15,939
-16,975
-52% -$334K 0.04% 306
2023
Q2
$746K Sell
32,914
-11,532
-26% -$232K 0.1% 245
2023
Q1
$873K Sell
44,446
-608
-1% -$11.7K 0.11% 243
2022
Q4
$775K Buy
+45,054
New +$799K 0.1% 242

Other funds holding RXO

Keeley-Teton Advisors's RXO Position: Q1 2025 in Review

Keeley-Teton Advisors reduced its RXO (RXO) stake by 5.9% in Q1 2025, selling an estimated $24.5K and leaving 17,928 shares worth $342K. The position accounts for 0.04% of the portfolio, ranked #323.

Keeley-Teton Advisors first reported a position in RXO in Q4 2022 and has held it in 10 quarters since. The position peaked at $873K in Q1 2023. 257 funds tracked by Wall St. Rank hold RXO as of Q1 2025.

  • Keeley-Teton Advisors held 17,928 shares of RXO worth $342K as of Q1 2025.
  • Keeley-Teton Advisors sold 1,118 RXO shares in Q1 2025, an estimated $24.5K.
  • RXO made up 0.04% of Keeley-Teton Advisors's portfolio in Q1 2025, its #323 holding.
  • Keeley-Teton Advisors first reported a position in RXO in Q4 2022 and has held it in 10 quarters since.
  • Keeley-Teton Advisors's RXO position peaked at $873K in Q1 2023.
  • 257 funds tracked by Wall St. Rank held RXO as of Q1 2025.

Based on Keeley-Teton Advisors's 13F filing for Q1 2025, filed 14 May 2025.